Acadian Asset Management
EDIT icon

Acadian Asset Management’s Editas Medicine EDIT Stock Holding History

Acadian Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Buy
1,457,715
+657,868
+82% +$1.39M 0.01% 790
2025
Q4 		$1.64M Buy
799,847
+443,189
+124% +$1.28M ﹤0.01% 968
2025
Q3 		$1.24M Sell
356,658
-35,510
-9% -$99.1K ﹤0.01% 1006
2025
Q2 		$861K Sell
392,168
-359,994
-48% -$589K ﹤0.01% 1012
2025
Q1 		$869K Buy
752,162
+558,567
+289% +$822K ﹤0.01% 965
2024
Q4 		$244K Buy
+193,595
New +$493K ﹤0.01% 1225

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Acadian Asset Management's EDIT Position: Q1 2026 in Review

Acadian Asset Management increased its Editas Medicine (EDIT) stake by 82% in Q1 2026, buying an estimated $1.39M and bringing the position to 1,457,715 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #790.

Acadian Asset Management first reported a position in EDIT in Q4 2024 and has held it in 6 quarters since. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Acadian Asset Management held 1,457,715 shares of Editas Medicine worth $3.6M as of Q1 2026.
  • Acadian Asset Management bought 657,868 Editas Medicine shares in Q1 2026, an estimated $1.39M.
  • Editas Medicine made up 0.01% of Acadian Asset Management's portfolio in Q1 2026, its #790 holding.
  • Acadian Asset Management first reported a position in Editas Medicine in Q4 2024 and has held it in 6 quarters since.
  • 208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.